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ABSTRACT The lung microbiota is commonly sampled using relatively invasive
bronchoscopic procedures. Exhaled breath condensate (EBC) collection potentially
offers a less invasive alternative for lung microbiota sampling. We compared lung
microbiota samples retrieved by protected specimen brushings (PSB) and exhaled
breath condensate collection. We also sought to assess whether aerosolized antibi-
otic treatment would inﬂuence the lung microbiota and whether this change could
be detected in EBC. EBC was collected from 6 conscious sheep and then from the
same anesthetized sheep during mechanical ventilation. Following the latter EBC
collection, PSB samples were collected from separate sites within each sheep lung.
On the subsequent day, each sheep was then treated with nebulized colistimethate
sodium. Two days after nebulization, EBC and PSB samples were again collected.
Bacterial DNA was quantiﬁed using 16S rRNA gene quantitative PCR. The V2-V3 re-
gion of the 16S rRNA gene was ampliﬁed by PCR and sequenced using Illumina
MiSeq. Quality control and operational taxonomic unit (OTU) clustering were per-
formed with mothur. The EBC samples contained signiﬁcantly less bacterial DNA
than the PSB samples. The EBC samples from anesthetized animals clustered sepa-
rately by their bacterial community compositions in comparison to the PSB samples,
and 37 bacterial OTUs were identiﬁed as differentially abundant between the two
sample types. Despite only low concentrations of colistin being detected in bron-
choalveolar lavage ﬂuid, PSB samples were found to differ by their bacterial compo-
sitions before and after colistimethate sodium treatment. Our ﬁndings indicate that
microbiota in EBC samples and PSB samples are not equivalent.
IMPORTANCE Sampling of the lung microbiota usually necessitates performing
bronchoscopic procedures that involve a hospital visit for human participants and
the use of trained staff. The inconvenience and perceived discomfort of participating
in this kind of research may deter healthy volunteers and may not be a safe option
for patients with advanced lung disease. This study set out to evaluate a less inva-
sive method for collecting lung microbiota samples by comparing samples taken via
protected specimen brushings (PSB) to those taken via exhaled breath condensate
(EBC) collection. We found that there was less bacterial DNA in EBC samples com-
pared with that in PSB samples and that there were differences between the bacte-
rial communities in the two sample types. We conclude that while EBC and PSB
samples do not produce equivalent microbiota samples, the study of the EBC micro-
biota may still be of interest.
KEYWORDS 16S rRNA, EBC, colistimethate sodium, colistin, lung microbiota,
respiratory microbiota, sheep
The study of the lung microbiota is a relatively new ﬁeld in comparison to other areasof microbiota research. Although an increasing number of studies are linking
changes in the composition of the lung bacterial communities to various disease states,
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including allergies, autoimmune disorders, and inﬂammatory and infectious diseases
(1), the protocols for studying the lung microbiota are not standardized, making
comparisons between studies difﬁcult.
One issue with studying the lung microbiota is the invasiveness of the sampling
techniques; the most common techniques are bronchoalveolar lavage (BAL) and the
collection of protected specimen brushings (PSB), both of which require the subject to
undergo bronchoscopy. The inconvenience and fear of complications associated with
bronchoscopic procedures can result in healthy and/or diseased individuals declining
to take part in studies (2), leading to a reduction in the potential pool of volunteers for
lung microbiota studies. It is also currently unknown whether these sampling methods
themselves can lead to changes in the lung microbiota.
Exhaled breath condensate (EBC) collection could potentially be a less invasive
method for taking lung microbiota samples. This method involves condensing exhaled
vapor into a liquid and has previously been used to study exhaled bacteria, viruses, and
fungi (3–8). However, there have been no studies using 16S rRNA gene sequencing to
compare the bacteria found in EBC samples to those found in samples taken directly
from the lungs. Therefore, it is not known whether it can be used as a surrogate for
more-invasive sampling techniques. We sought to assess the feasibility of using EBC in
sheep to study the lung microbiota composition. We have previously used sheep as a
model for studying the lung microbiota (9, 10) due to the anatomical and immuno-
logical similarity of their lungs to those of humans (11–13). In this study, we compared
EBC samples collected from conscious sheep and from the same sheep under anes-
thesia to PSB samples taken from four spatially disparate sites within the lungs.
We then extended this to address whether EBC analysis has the capacity to detect
changes in bacterial community compositions by attempting to directly manipulate the
lung microbiota with an inhaled antibiotic (colistimethate sodium [CMS], which is active
against Gram-negative bacteria). In a previous study, we examined the effect of
intravenous CMS on the lung microbiota (9). While we did identify changes in the lung
microbiota composition, the longer-term systemic antibiotic treatment used in that
study also likely affected the gut microbial populations. Immunological links between
gut and lung immunities, the gut-lung axis, raise the possibility that such changes may
have indirectly inﬂuenced the lung microbiota (14). In this study, we delivered nebu-
lized CMS, since this has been shown to lead to lower colistin plasma concentrations
than injected CMS (15), enabling us to discern the direct effect of antibiotic treatment
on respiratory bacterial communities.
A far greater quantity of bacterial DNA was isolated from PSB samples relative to EBC
samples. We found that while there was some overlap between the types of bacteria
found in these samples, EBC samples did cluster separately from PSB samples by their
bacterial community compositions. Lastly, despite our antibiotic treatment regime only
producing low concentrations of colistin in the lung epithelial lining ﬂuids (the prodrug
CMS is hydrolyzed in vivo to the active form of the drug, colistin), signiﬁcant differences
in community compositions were found between PSB samples derived pre- and
posttreatment.
RESULTS
Analysis of sequence quality and controls. DNA was extracted from respiratory
samples and controls, and the V2-V3 variable regions of the 16S rRNA gene were
ampliﬁed by PCR and then sequenced. After forming contigs from forward and reverse
reads, various quality control steps were undertaken, which reduced the total sequence
numbers by 25.8%. The lowest Good’s coverage estimate value among the samples was
0.996, indicating that at least 99.6% of the bacteria in this sample were identiﬁed. The
sequence error rate was 0.18% and the average number ( standard deviation [SD]) of
reads per sample was 39,195 11,535. In total, 867 operational taxonomic units (OTUs)
were identiﬁed.
The Human Microbiome Project mock community HM-783D, containing the 16S
rRNA genes of 20 bacterial species in staggered quantities and ﬁxed ratios (1,000 to
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1,000,000 copies per organism per l), was processed alongside the samples. Some
biases were identiﬁed (see Data Set S2 in the supplemental material). Three species
were incorrectly identiﬁed at the species level (Acinetobacter baumannii was misiden-
tiﬁed as Acinetobacter rhizosphaerae, Clostridium beijerinckii was misidentiﬁed as Clos-
tridium butyricum, and Neisseria meningitidis was misidentiﬁed as Neisseria cinerea). Two
of the bacterial species which were present in low numbers in the original community
were not identiﬁed at any taxonomic level, namely, Actinomyces odontolyticus and
Bacteroides vulgatus. Their absence is likely due to the fact that they were in low
abundance rather than the inability of our protocol to amplify and identify them, as
they have previously been identiﬁed using the same protocol on a nonstaggered
version of the same mock community (10). We were also previously able to identify
Enterococcus faecalis at the genus level, whereas in this study, it could not be identiﬁed
except potentially as OTU 10, Bacilli (class). This discrepancy, combined with the fact
that E. faecalis is in low abundance in the staggered mock community, leads us to
believe that this identiﬁcation is incorrect.
As lung bacteria are in low abundance, lung samples are at a particular risk for
contamination by bacterial DNA originating from DNA extraction kit reagents. There-
fore, as well as mock community controls, DNA extraction kit reagent controls were
produced. DNA was extracted from samples in four batches and a reagent control was
included with every batch. The bacterial OTUs identiﬁed in the extraction kit controls
did not occur consistently in samples from the same batch (Fig. 1). Samples were
clustered by DNA extraction batch (P  0.001 by analysis of molecular variance
[AMOVA]), and 30 OTUs were found to be indicative of speciﬁc batches (see Data Set
S3). However, when these OTUs were removed from the data set, samples still clustered
by extraction batch (P  0.014 by AMOVA), indicating that clustering was not entirely
due to the presence of these OTUs. It is possible that some of these OTUs may be found
naturally within the sheep respiratory system (e.g., Micrococcus luteus, a common
colonizer of the human upper respiratory tract). Therefore, we decided not to remove
these OTUs from our data set. Since samples were randomly assigned to extraction
batches, clustering by batch would be unlikely to lead to false-positive statistical results.
However, there is the possibility that the presence of contaminating organisms may
increase the heterogeneity and thereby also increase stochastic noise.
In controls, the most abundant OTUs on average were as follows: Corynebacterium,
14.4%; Enterobacteriaceae, 10.9%; and Intrasporangiaceae, 3.6% in PSB controls and
Burkholderia, 14.0%; Neisseriaceae, 10.5%; and Aggregatibacter, 7.7% in DNA extraction
kit reagent controls. The most abundant OTUs (on average) in the different sample
types were as follows: Staphylococcus equorum, 10.7%; Mannheimia, 6.5%; and Staph-
ylococcus sciuri, 5.6% in PSB samples; Staphylococcus equorum, 5.5%; Neisseriaceae,
4.7%; and Paracoccus, 4.3% in EBC samples from conscious sheep (cons); and Staphy-
lococcus equorum, 5.1%; Staphylococcus epidermidis, 3.7%; and Peptostreptococcus an-
aerobius, 3.2% in EBC samples from anesthetized sheep (anaes).
PSB samples contain more bacterial DNA than EBC samples. The V3 region of the
16S rRNA gene was quantiﬁed in our samples using quantitative PCR (qPCR). On
average, PSB samples contained 1.53  105  2.96  105 ng/l (mean  SD)
bacterial DNA (34,200  66,100 16S copy numbers/l), while EBC samples from
conscious and anesthetized sheep contained 4.28  107  5.34  107 ng/l (955 
1,190 16S copy numbers/l) and 2.38  107  7.12  108 ng/l (531  159 16S
copy numbers/l), respectively (Fig. 2). DNA extraction kit reagent controls contained
1.82  107  2.21  108 ng/l (406  49 16S copy numbers/l), while PSB controls
and qPCR water controls contained 1.84  107  1.05  108 ng/l (411  23 16S
copy numbers/l) and 1.98  107  2.06  108 ng/l (442  46 16S copy
numbers/l), respectively.
All respiratory samples contained signiﬁcantly more DNA than the controls (P 
0.005 for all sample types by Mann-Whitney U test). EBC samples from conscious and
anesthetized animals did not contain signiﬁcantly different quantities of DNA (P 
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FIG 1 Heatmap showing samples grouped by batch based on the time DNA was extracted from the samples. Bacterial OTUs were included where
they had an abundance of 5% in at least one sample. OTUs which were 5% abundant in a DNA extraction kit reagent control are indicated
by color (batch 1, green; batch 2, pink; batch 3, blue; and batch 4, yellow). DNA extraction kit reagent controls are labeled as Extraction Kit Batch
1 to 4. EBC samples from conscious and from anesthetized sheep are labeled EBC (cons) and EBC (anaes), respectively. OTUs which were 5%
abundant in an extraction kit control do not consistently appear in all samples in the same batch.
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0.182 by Wilcoxon signed-rank test); however, PSB samples contained signiﬁcantly
more DNA than both EBC (cons) (P  0.002 by Wilcoxon signed-rank test) and EBC
(anaes) (P  0.002 Wilcoxon signed-rank test) samples.
No signiﬁcant clustering of EBC by sampling method. Since EBC samples from
conscious sheep would be expected to include more bacteria from the upper respira-
tory tract than EBC samples from anesthetized sheep, it was expected that these two
groups of samples would cluster separately from one another. However, no signiﬁcantly
separate clustering was observed (P  0.994 by AMOVA). Despite this lack of separate
clustering, EBC samples taken from the same sheep while it was conscious or anesthe-
tized did not contain the same bacterial communities, as can be observed in Fig. 3.
The richness and the diversity of bacterial communities were not signiﬁcantly
different between the two groups (P  0.583 and P  0.595, respectively, by Wilcoxon
signed-rank test). When examined using Metastats, there were signiﬁcant differences in
the quantities of several OTUs between these groups, but all of these OTUs were
present at low abundances (1% abundant on average in each group).
PSB samples and EBC (anaes) samples cluster separately by their bacterial
communities. We next investigated whether PSB and EBC samples contained equiva-
lent bacterial communities. We compared PSB samples with EBC (anaes) samples as we
hypothesized that these would be less likely to be contaminated by upper respiratory
tract microbes than EBC (cons) samples. As well as containing a larger quantity of
bacterial DNA, PSB samples also contained bacterial communities that were signiﬁ-
cantly different from those of the EBC (anaes) samples (P  0.011 by AMOVA) (Fig. 4).
This may be explained by the difference in variation between the two groups (P 
0.026 by homogeneity of molecular variance [HOMOVA]). Bacterial communities from
PSB samples were also found to be signiﬁcantly richer (P  0.006 by Wilcoxon
signed-rank test), but there was no signiﬁcant difference in diversity (P  0.48 by
Wilcoxon signed-rank test). One OTU designated Pseudomonas veronii, which was the
4th most abundant OTU in PSB samples, was found to be signiﬁcantly more abundant
in PSB samples (PSB samples [mean  SD], 3.9%  1.3%; EBC, only one sequence read
FIG 2 Boxplot showing the log 16S rRNA gene concentrations found in sheep respiratory samples (EBC
samples from conscious and anesthetized animals and PSB samples) and controls (protected specimen
brushes, DNA extraction kit reagents and qPCR reagents). Outliers were deﬁned by SPSS as either “out”
values (circles) or “extreme” values (stars). PSB samples contained signiﬁcantly more bacterial DNA (P 
0.005) than any other respiratory sample type or control.
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found in one sample; Metastats q value  0.046). The P. veronii OTU was not found in
any of the PSB controls, indicating that its presence is not likely due to contamination.
This indicates that the EBC samples do not simply contain a subset of the most
abundant OTUs from PSB samples. An additional 36 low-abundance OTUs (1%
abundant on average in either group) were found to be signiﬁcantly different between
the two groups by Metastats.
We considered that since EBC (anaes) samples contained far less bacterial DNA than
PSB samples, they may have been more affected by contamination and this may be
why these sample types clustered separately. However, the ﬁve most abundant OTUs
found in DNA extraction kit reagent controls (Burkholderia, Neisseriaceae, Aggregatibac-
ter, Pseudomonadaceae, and Methylobacterium) were not found to be signiﬁcantly
differently represented between PSB samples and EBC (anaes) samples (Metastats q
value 1). Therefore, it seems unlikely that the separate clustering of these groups was
due merely to the increased effect of contamination on EBC (anaes) samples.
Changes in the bacterial communities found in respiratory samples before and
after CMS treatment. For both EBC (cons) and EBC (anaes) samples, pre- and post-
treatment samples did not differ signiﬁcantly by bacterial community structure (P 
FIG 3 Heatmap showing EBC samples grouped by sheep and time point. DNA extraction kit reagent controls are labeled as Extraction Kit Batch 1 to 4. EBC
samples from conscious and anesthetized sheep are labeled EBC (cons) and EBC (anaes), respectively. Bacterial OTUs were included where they had an
abundance of 5% in at least one sample. As can be observed, EBC samples taken from the same sheep when it was conscious and when it was anesthetized
did not necessarily contain the same bacterial OTUs.
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0.449 and P  0.094, respectively, by AMOVA). However, the bacterial communities
found in PSB samples were found to be signiﬁcantly different pre- and posttreatment
(P 0.014 by AMOVA) (Fig. 5). This signiﬁcantly separate clustering was not merely due
to differences in variation between the two groups (P  0.87 by HOMOVA). The OTU P.
veronii was increased in posttreatment samples (pretreatment [mean  SD], 0.74% 
0.39%; posttreatment, 7.1%  2.4%; Metastats q value  0.043), and a further 97
low-abundance (0.1%) OTUs were found to signiﬁcantly differentiate pre- and post-
treatment samples.
Using the Wilcoxon signed-rank test, it was found that the concentrations of DNA in
respiratory samples before and after CMS treatment did not differ signiﬁcantly: PSB
samples, P 0.689; EBC (cons) samples, P 0.345; and EBC (anaes) samples, P 0.248.
The concentrations of colistin A identiﬁed in sheep lungs are shown in Table 1.
DISCUSSION
In this study, we sought to identify whether invasive lung microbiota sampling
techniques could be replaced by a less invasive method. We compared the quantities
of bacterial DNA and the bacterial communities from samples taken by PSB and EBC
collection in six sheep at two sampling points. EBC was collected from both conscious
and anesthetized animals. During mechanical ventilation, the animals were intubated,
meaning that the exhaled breath collected was derived only from the lower respiratory
tract. By comparing these samples to those taken from conscious animals, it should be
FIG 4 PCoA graph showing the signiﬁcantly separate clustering of EBC (anaes) and PSB samples from sheep (P  0.011 by
AMOVA), which may be due to the difference in variation between the two sample types (P  0.026 by HOMOVA). The OTUs
which most contributed to samples moving in a positive or negative direction along either axis and which had P values of 
0.00058 (deﬁned by Bonferroni’s correction as 0.5 divided by the total number of OTUs), according to the corr.axes command
within mothur, are listed. As this graph is only representative of 20.3% of the total variability present between samples, caution
should be taken when interpreting how clustered the sample groups appear.
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possible to analyze the extent of contamination by bacteria from the upper respiratory
tract in EBC (cons) samples. We found that EBC samples contained signiﬁcantly less
bacterial DNA than the PSB samples and that PSB samples clustered separately from
EBC (anaes) samples by the composition of their bacterial communities. EBC (anaes)
and EBC (cons) samples did not cluster separately from one another.
Studies examining the utility of EBC for identifying lung-colonizing microorganisms
have shown variable results. A study comparing EBC and sputum samples from asthma
patients showed a 100% overlap in the culturable fungi identiﬁed between the two
sample types (5), and a study examining the bacterial pathogens cultured from BAL and
EBC samples in patients with ventilator-associated pneumonia showed a high concor-
dance between the two sampling methods (16). In comparison, when PCR assays for 10
FIG 5 PCoA graph showing the signiﬁcantly separate clustering of PSB samples from sheep before and after CMS treatment
(P  0.014 by AMOVA). The OTUs which most contributed to samples moving in a positive or negative direction along either
axis and which had P values of  0.00058 (deﬁned by Bonferroni’s correction as 0.5 divided by the total number of OTUs),
according to the corr.axes command within mothur, are listed. As this graph is only representative of 24% of the total
variability present between samples, caution should be taken when interpreting how clustered the sample groups appear.
TABLE 1 Colistin A concentrations in sheep epithelial lining ﬂuid
Sheep
Colistin A concna
(ng/l)
Dilution of epithelial
lining ﬂuid in BAL
Mean colistin A concn
corrected for dilution
(ng/l)
ED951 0.346 0.056 5.45 1.89
ED952 0.320 0.034 4.18 1.34
ED953 0.290 0.061 6.45 1.87
ED954 1.549 0.251 15.75 24.40
ED955 0.625 0.159 11.43 7.15
ED956 0.222 0.017 29.5 6.56
aValues are the means  SD. Colistin B values were too low to be calculated accurately.
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common respiratory pathogens were performed on EBC and sputum samples from
chronic obstructive pulmonary disease patients, the results were found not to correlate
well (17). EBC collection has also previously been found to be inefﬁcient for detecting
Mycobacterium tuberculosis (18), inﬂuenza viruses (19), and the common cystic ﬁbrosis
pathogens Pseudomonas aeruginosa and Burkholderia cepacia (20).
Some concerns have been raised about the use of EBC in respiratory research, since
the epithelial lining ﬂuid contained in these samples is often variable and is very highly
diluted with water vapor (21). This dilution could explain the far lower concentrations
of bacterial DNA we identiﬁed in EBC samples in comparison to those from PSB
samples. It is also likely that PSB would be more efﬁcient for sampling bioﬁlms adhered
to the lung mucosa, which could explain some of the differences observed between the
two sample types. The difference between the bacterial communities found in PSB and
EBC samples may also be partially explained by how EBC is formed. The exact origin of
EBC is still under debate, but it has been suggested that differences observed between
BAL and EBC samples could be explained by the fact that different compartments of the
lung are sampled (22). While it might be assumed that EBC would be derived from both
the central and peripheral airway compartments, which would perhaps explain the
differences between these samples and PSB samples, Bondesson et al. concluded that
the majority of EBC is in fact derived from the central airways (23). Without a better
understanding of how EBC is formed and what inﬂuences its composition, we are
unable to account for the differences we observed between the two sampling types.
Despite the fact that the concentrations of colistin found in the lungs were quite low
after nebulized CMS treatment, a signiﬁcant difference was observed in the bacterial
communities from PSB samples pre- and posttreatment. In a previous study, we found
that the relative proportion of Gram-negative bacteria in the lung microbiota (exclud-
ing Pseudomonadales) was reduced after injected CMS treatment (9). However, mem-
bers of Pseudomonadales generally increased in relative abundance or remained stable
after treatment. Therefore, it is interesting to note that while in this study we did not
ﬁnd a signiﬁcant reduction in the abundance of Gram-negative bacteria in PSB samples
(data not shown), an OTU belonging to Pseudomonadales (P. veronii) was signiﬁcantly
increased in these samples after CMS treatment. It is possible that, even at low
concentrations, the colistin may have had some effect on the lung bacteria or that the
sampling strategy may itself in some way lead to changes in the lung microbiota, but
at the moment, this is purely speculative. All samples were randomized prior to DNA
extraction and PCR ampliﬁcation; therefore, the observed differences were not due to
samples from one time point being processed separately from those from the other
time point.
In conclusion, the differences we observed between PSB samples and EBC samples
lead us to not recommend using EBC collection as a replacement for more-invasive
lung sampling techniques. However, the EBC microbiota may still be an interesting
avenue of study despite the fact that the small quantities of bacterial DNA in these
samples leave them more vulnerable to contamination, and any future studies would
have to be designed with this in mind.
MATERIALS AND METHODS
Animals. Six commercially sourced, castrated male Suffolk-cross sheep aged 14 months were used
in this study. All animal experiments were approved by the Roslin Institute Animal Welfare and Ethics
Committee and were subject to the Animals (Scientiﬁc Procedures) Act of 1986. Sheep had previously
been housed outdoors as part of a large ﬂock but were moved indoors before the study and remained
indoors until the study end. Sheep were separated into two pens sharing the same airspace. One pen
contained sheep ED951, ED952, and ED953, while the other contained sheep ED954, ED955, and ED956.
The rectal temperatures and weights of all animals were taken prior to the initial respiratory tract
sampling. The animals weighed on average ( SD) 49.2  3.4 kg and the rectal temperatures were
measured as 38.9  0.89°C.
Experimental design. Conscious animals were conﬁned in a yoke head-restraint holding crate, and
EBC was collected for 10 min using an RTubeVENT with a cooling sleeve (Respiratory Research,
Charlottesville, VA, USA) attached to a face mask. The sheep inhaled through a one-way inspiratory valve
and expired through the RTubeVENT (Fig. 6). The exhaled breath condensate samples from conscious
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sheep (EBC [cons]) were transferred from the RTubeVENT into Eppendorf tubes according to the
manufacturer’s instructions and were frozen on dry ice within an hour of collection.
The sheep were then anesthetized (3 to 5 h later) according to a procedure that has previously been
described (24). Bronchoscopy was performed using an endotracheal tube. During anesthesia, EBC
samples were collected for 10 min by incorporating an RTubeVENT within the expiratory limb of the
anesthetic circuit (Fig. 6). The condensate was again transferred into Eppendorf tubes. The exhaled
breath condensate samples from the anesthetized sheep (EBC [anaes]) were frozen on dry ice within an
hour of collection. PSB samples (disposable microbiology brush; Conmed, Utica, NY, USA) were taken
from the left ventral diaphragmatic 1 (LVD1), right ventral diaphragmatic 1 (RVD1), right caudal
diaphragmatic (RCD), and left caudal diaphragmatic (LCD) lung segments (Fig. 7). Brushes were cut into
phosphate-buffered saline (PBS; Sigma-Aldrich, Irvine, UK) for storage. For each sampling day, an unused
protected specimen brush was cut into PBS to act as a control.
Eighteen hours after the recovery from anesthesia, sheep were administered 2,000,000 IU of CMS in
4 ml distilled water by inhalation (Colomycin for injection; Forest Laboratories UK Ltd., Dartford, UK).
Restraint of the conscious sheep was as described above, and the CMS was delivered using a face
mask connected via the inspiratory limb to an eFlow rapid nebulizer (PARI Respiratory Equipment
Inc., Midlothian, VA, USA). This treatment was repeated 6 h later. Two days after the ﬁrst CMS dose
was administered, EBC (cons), EBC (anaes), and PSB samples were again collected as described
above. Sheep were killed by barbiturate overdose and exsanguination and blood samples were
collected. Blood was centrifuged at 2,500  g for 5 min and the serum was removed and frozen on
dry ice. Immediately postmortem, 20-ml aliquots of PBS were used to collect BAL ﬂuid. The urea
concentrations in plasma and BAL ﬂuid were used to calculate the dilution factor of lung epithelial
lining ﬂuid in BAL ﬂuid (25).
Quantitation of colistin in BAL ﬂuid of sheep. BAL ﬂuid was centrifuged at 1,400  g for 5 min to
remove cells prior to colistin quantiﬁcation. The quantitation of colistin in ovine BAL ﬂuid essentially
follows the method previously published by Marchand et al. (26). Brieﬂy, colistin sulfate (item no. 17584
[mixture of A and B isoforms]; Cayman Chemicals, Ann Arbor, Ml, USA) was dissolved in H2O to 1 mg/ml
and a series of 7 calibrant solutions were created by diluting the stock solution into blank BAL ﬂuid to
cover the range from 100 to 0.07 g/ml. Polymyxin B (Sigma-Aldrich, Irvine, UK) was used as an internal
standard and was dissolved in water to 300 g/ml. Two microliters of internal standard was added
to 200 l of each of the calibrant solutions and to 200 l of each of the test samples. Eight hundred
microliters of a solution of H2O and 0.1% (vol/vol) formic acid was added to each of the samples/
calibrants, and each was partially puriﬁed by binding to a DSC-18 SPE cartridge (Sigma-Aldrich,
Irvine, UK) and eluted with 400 l methanol (MeOH) and 0.1% (vol/vol) formic acid. The eluted
fractions were dried under vacuum and reconstituted in 50 l of H2O and 0.1% (vol/vol) formic acid
for subsequent analysis.
All calibrants and samples were centrifuged at 13,000 g for 5 min to pellet any precipitate and then
were analyzed by online liquid chromatography tandem-mass spectrometry (LC-MS/MS) in duplicate.
Aliquots of 5 l were injected into an Ace Ultracore 2.5 SuperC18 high-performance liquid chromatog-
raphy (HPLC) column (75 mm by 2.1 mm) preequilibrated with 98% (vol/vol) buffer A, where HPLC buffer
A was H2O with 0.1% (vol/vol) formic acid and 0.01% (vol/vol) triﬂuoroacetic acid, while HPLC buffer B
was acetonitrile with 0.1% (vol/vol) formic acid and 0.01% (vol/vol) triﬂuoroacetic acid. The HPLC
separation was developed by the following steps: from 2% buffer B at 0 min to 18% buffer B at 1 min,
22% buffer B at 3.5 min, 100% buffer B at 4 min, 100% buffer B at 5 min, and returning to 2% buffer B
at 6 min for 5 min to reequilibrate. The ﬂow rate was 200 l/min and the eluent was passed directly to
FIG 6 (A) EBC was collected from conscious animals while they were restrained in a yoke head-restraint
holding crate. A face mask was attached and sheep inhaled through a short tube with an inlet valve and
exhaled through an RTubeVENT. (B) EBC was collected from anesthetized mechanically ventilated
animals by placing the RTubeVENT in-line with the expiratory limb of the ventilator, near the sheep’s
head.
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the electrospray source of an Amazon ETD ion trap mass spectrometer (Bruker, Billerica, MA, USA)
operated in positive-ion mode. The mass spectrometer was operated under multiple reaction monitoring
conditions, using parent ions of 578.3, 585.3, and 602.3 (representing the double-charged ion of colistin
B, colistin A, and polymyxin B, respectively), fragmentation amplitudes of 0.8, and cutoffs of 140 in each
case. Calibration curves and colistin concentrations were calculated by Bruker’s proprietary software
QuantAnalysis using the following reporter ions: 526.3, 535.3, 567.3, and 576.3 (colistin A); 519.3, 528.3,
560.800, and 569.3 (colistin B); and 543.300, 552.300, 584.300, and 593.3 (polymyxin B).
DNA extraction. DNA extraction was carried out as described previously (10) using the Mo Bio
PowerSoil DNA isolation kit (Mo Bio Laboratories Inc., Carlsbad, CA, USA). All DNA extractions were
carried out using extraction kits from the same lot, as the contamination present in different lots of the
same make of kit has been shown not to be consistent (27). Samples were randomly assigned to one of
four DNA extraction batches, and for each of these batches, an extraction kit reagent-only control was
produced (sample groupings can be found in Data Set S1 in the supplemental material).
16S rRNA gene ampliﬁcation and sequencing. The V2-V3 variable regions of the 16S gene were
ampliﬁed as described previously (10). A nested PCR protocol was used to decrease the potential bias
introduced by the use of barcoded primers by only including primers with Illumina adaptor sequences
and barcodes in the second PCR round (28). The ﬁrst round used the V1-V4 primers 28F (5=-GAGTTTG
ATCNTGGCTCAG-3=) and 805R (5=-GACTACCAGGGTATCTAATC-3=) and the second round used the V2-V3
primers 104F (5=-GGCGVACGGGTGAGTAA-3=) and 519R (5=-GTNTTACNGCGGCKGCTG-3=) with Illumina
adaptor sequences and barcodes (Data Set S1). The PCR conditions for the ﬁrst round were 94°C for 2 min
followed by 20 cycles of 94°C for 1 min, 55°C for 45 s and 72°C for 1.5 min, followed by 72°C for 20 min.
The conditions for the second round were 98°C for 30 s followed by 20 cycles of 98°C for 10 s, 67°C for
30 s, and 72°C for 10 s, followed by 72°C for 2 min. Q5 High-ﬁdelity 2master mix (New England BioLabs,
Ipswich, MA, USA) was used for all reactions. After each PCR round, amplicons were puriﬁed using the
AMPure XP PCR puriﬁcation system (Beckman Coulter, Brea, CA, USA). The Human Microbiome Project
mock community HM-783D (obtained through BEI Resources, NIAID, NIH) also underwent PCR alongside
samples and controls. The Qubit dsDNA HS assay kit (Thermo Fisher Scientiﬁc, Hemel Hempstead, UK)
was used to calculate the quantity of DNA in each sample, and then samples were pooled into a
sequencing library. Sequencing was performed using Illumina MiSeq (Illumina, San Diego, CA, USA)
producing 250-bp paired-end reads.
Bioinformatic and statistical analysis. Primers were removed with cutadapt (29) and sequences
with greater than one base error per 10 bases were discarded. Quality control, taxonomic assignment,
and OTU clustering were performed in mothur (30) as described previously (10). The data were
FIG 7 Diagram of the sheep lung. PSB samples were taken before and after colistimethate sodium
treatment from the right ventral diaphragmatic 1 (RVD1), left ventral diaphragmatic 1 (LVD1), right caudal
diaphragmatic (RCD), and left caudal diaphragmatic (LCD) lung segments. RC, right cardiac; RA, right
apical; LC, left cardiac; LVD2, left ventral diaphragmatic 2; RVD2, right ventral diaphragmatic 2. Adapted
from reference 24.
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subsampled to the minimum number of sequence reads found in one of our samples (11,675). Except
where stated, the following analyses were all performed within mothur.
Good’s coverage values were calculated to estimate sample coverage (31). Distance matrices were
constructed using Yue-Clayton theta values (32), and AMOVA was used to compare groups of samples
by their bacterial composition (33). HOMOVA was used to compare groups by their variation (34).
Principal-coordinate analysis (PCoA) graphs were constructed to visualize sample clustering. The mothur
command corr.axes was used to correlate bacterial OTUs to the axes of the PCoA graphs using the
Spearman’s rank correlation coefﬁcient (r). Bonferroni’s correction was used to correct for multiple
statistical tests. The inverse Simpson’s index was employed to measure microbial diversity and the Chao
1 index was employed to measure richness. Metastats was used to identify OTUs which were signiﬁcantly
different between groups (35) except where more than two groups were compared, in which case
indicator analysis was used (36).
To compare groups statistically when data were nonparametric, the Mann-Whitney U test was used
if the groups were independent and the Wilcoxon signed-rank test was used when samples were related
(performed in SPSS Statistics 21; IBM Analytics). Boxplots for qPCR data were constructed in SPSS.
Heatmaps were constructed in R (version 3.2.2; R Foundation for Statistical Computing) using the
packages gplots (37), heatplus (38), RColorBrewer (39), and Vegan (40).
qPCR. Quantiﬁcation of the V3 region of the 16S rRNA gene was carried out using a previously
described method (10). A standard curve was generated using DNA extracted from Pseudomonas
aeruginosa strain PA0579 using 9 serial dilutions ranging from 14.2 ng/l to 1.42  107 ng/l
(quantiﬁed by the Qubit dsDNA HS assay). The 0.142 ng/l dilution served as a positive control for all
qPCRs. The average threshold cycle (CT) value of no-template controls was 28.7.
qPCR was performed using 1 l of extracted DNA solution, the primers UniF340 (5=-ACTCCTACGG
GAGGCAGCAGT-3=) and UniR514 (5=-ATTACCGCGGCTGCTGGC-3=) at a ﬁnal concentration of 0.4 M, and
the LightCycler 480 SYBR green I master mix (Roche Applied Science, Mannheim, Germany). The qPCR
run consisted of a preincubation step (50°C for 2 min and 95°C for 10 s), an ampliﬁcation step (45 cycles
of 95°C for 30 s and then 63°C for 30 s), and a melting cycle.
Accession number(s). Sequencing reads can be accessed under BioProject accession number
PRJNA337937.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/AEM
.00515-17.
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